Clinical Trial

Clinical Implementation of TNM-immunoscore in Resected Non-small Cell Lung Cancer

Study acronym: TNM-I
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to validate TNM-Immunoscore in resected non-small cell lung cancer.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2017-09-27; most recent amendment 2024-06-10.
Status change: Recruiting → Active, Not Recruiting 2022-01-06
Trial Details
NCT Number NCT03299478
Lead Sponsor University Hospital of North Norway
Collaborators: Norwegian Cancer Society, Northern Health Authority, St. Olavs Hospital, Rigshospitalet, Denmark, Odense University Hospital, Oslo University Hospital, University of Tromso
Conditions Non-Small Cell Lung Cancer
Enrollment 865 participants
Start Date 2016-11-28
Primary Completion 2027-02-01 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2024-06-11